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Abstract
With nearly 3,800,000 cases and 270,000 deaths reported worldwide, COVID-19 is a global 
pandemic unlike any we have seen in our lifetimes (1). As early as 1995, the WHO was warning 
of a global infectious disease crisis, citing 30 new infectious diseases emerging in the past 
20 years, loss of antibiotic effectiveness, low rates of immunization, poverty, and inadequate 
investment in public health contributing to the more than 17 million people dying each year 
from infectious diseases, principally in Low and Middle Income countries (LMIC) (2). Unlike 
previous infectious diseases, at the time of this writing over 63% of the total reported cases of 
COVID-19 are in 6 High Income Countries (HIC): USA, Italy, Spain, France, Germany and the UK.
Information concerning the imaging findings in COVID-19 has been rapidly disseminated from 
the centers first affected by the pandemic. This article attempts to summarize the current state 
of knowledge regarding the imaging findings in COVID-19, focusing on pulmonary findings, 
and offer recommendation for the use of imaging for diagnosis and surveillance of COVID-19, 
particularly in LMIC.
Imaging findings
Regardless of modality, imaging is not able to distinguish COVID from other viral pneumonias. 
Nevertheless, for patients with the appropriate clinical presentation, during the current COVID 
pandemic the imaging findings described below point towards COVID causation. The high 
positive predictive values for imaging findings reported in many recently published papers is 
directly related to the high prevalence and pretest probability of COVID infection during this 
pandemic. For readers unfamiliar with the current terminology for chest radiography, chest CT, 
and pulmonary ultrasound in COVID, modality-specific terminology is listed in Addendum 1. 
Chest radiography 
The reported sensitivity of chest radiography (CXR) for COVID-19 varies widely from 25-69% (3). 
One report of high sensitivity (95%) included only patients admitted to the ICU and therefore 
with severe symptoms (4). In the subset of symptomatic patients with a negative RT-PCR test, 
only 9% of patients are reported to have CXR findings consistent with COVID-19 (3).
Initial findings on CXR are characterized as bilateral (50%), peripheral (41%), lower lobe (50%), 
with either ground glass opacities [GGO] (33%; Figure 1) or consolidation (47%; Figure 2) (3,5,6). 
Effusion is rarely present. Chest X-ray is less sensitive than CT, particularly in early disease. 
In a quantitative comparison with CT, radiography underestimated the extent and size of 
pulmonary findings (6). 
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The frequency of CXR findings increased with time and 
were most prominent and extensive 10 to 12 days from 
symptom onset (3,7,8). While Young et al. report that some 
patients’ chest X-rays remained normal during their course 
of hospitalization, two thirds of their population had either 
mild or moderate disease not requiring supplemental 
oxygen. 
Chest CT 
Chest CT was initially touted for use in the diagnosis of 
COVID-19 with a report from China of sensitivity exceeding 
RT-PCR testing (98% vs. 71%) and the authors suggesting 
using CT to screen patients for COVID-19 (9). While CT does 
have some role in COVID-19 infection, more recent reports 
have found that CT findings increase during the course of the 
disease (Figure 3) with up to 56% of patients having a normal 
CT at presentation (10). 
The principle findings on CT are ground glass opacities 
(GGO; Figures 1, 4) and consolidation (Figure 5) (5,11,12). 
GGO, the most common finding, occurs either alone (34%) 
or in association with consolidation (41%). Pulmonary 
involvement is variable but most often bilateral, multilobar, 
peripheral, and with a mild lower lobe predominance 
(3,5,7,10,11,13–15). Certain findings occur rarely and should 
prompt consideration of alternative or secondary diagnoses 
including: consolidation without ground glass opacity, 
pulmonary nodules, cavitation, mucoid impaction, and 
pleural effusion (13,15–17). While lymphadenopathy was 
initially viewed as rare with COVID-19 infection, recent 
reports from France and China suggest that in patients 
with moderate or severe disease, hilar or mediastinal 
lymphadenopathy (Figure 6) may be present in more than 
30% of this subset of patients (18,19). 
At initial presentation, early disease may manifest as GGO 
and/or crazy-paving (GGO with septal thickening; Figure 7) 
(12,13,15,20). Within one to three weeks, these opacities often 
progress into a more extensive mixed pattern of ground 
glass and consolidation (Figure 8 A-B) (11,12,15,20). Irregular 
septal thickening, reticular pattern, reverse halo (atoll sign) 
morphology (Figure 9), and linear/curvilinear opacities 
(Figure 10) have all been reported (10,11,15,16). With time, 
initial ground glass opacities and consolidation regress but 
the majority of patients have residual ground glass opacities 
upon hospital discharge (Figure 8 C-D) (12,20). CT findings 
progress and evolve in many patients with moderate 
or severe disease with reports showing consolidation 
developing into patterns of perilobular organizing 
pneumonia (Figure 11), suggesting possible progression to 
fibrosis—although these findings have not been evaluated 
long-term and fibrosis has not yet been histopathologically 
confirmed (11,12,15,17,21). 
The clinical significance and management implications of 
CT findings remain uncertain. Positive CT findings have 
been reported in asymptomatic patients (15). In a study of 
RT-PCR positive passengers from an infected cruise ship, 
over half of asymptomatic patients had a positive CT with 
a strong predominance of GGO over consolidation (83%); 
symptomatic patients had a higher rate of CT positivity 
(79% vs. 54%) and a predominance of consolidation over 
GGO (22). One group reported CT mixed patterns of ground 
glass opacities and consolidation were more common in 
patients outside the ICU and consolidation predominated 
in ICU patients (23). This higher-than-expected prevalence 
of abnormal CT findings in infected patients, regardless of 
symptomology, reinforces the judicious use of CT imaging in 
guiding treatment and patient disposition. 
Artificial intelligence (AI) has been demonstrated, in a 
retrospective trial, to improve radiologists’ performance on 
CT in distinguishing between pneumonia from COVID-19 
compared to other infections but the clinical impact of such 
technology is yet to be determined (24).
A detailed description of non-pulmonary COVID-19 related 
imaging findings is beyond the scope of this article. CT 
scanning, and MRI, if available, is being for neurodiagnosis 
in those COVID-19 patients who have been reported to 
experience cerebrovascular events and encephalitis.
Ultrasound
A standardized acquisition protocol, using 14 designated 
landmarks, has been proposed by Soldati and colleagues 
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Figure 2. Multiple peripheral consolidations bilaterally. 
(Choi et al., used with permission)
Figure 1. Ground glass opacities as observed on CXR (left) 
and CT (right). (Yoon et al., licensed under CC BY-NC 4.0)
and is recommended to allow for serial comparison (25). 
Scoring of abnormalities can be performed using a 3-point 
scale (Figure 12).
Ultrasound findings are notable for pleural and septal 
thickening (25-27), indicating subpleural interstitial fluid 
or consolidation extending to the pleural edge. As with CT 
and radiography, pleural effusions are rarely observed on 
ultrasound (26). 
Ultrasound can also be used for cardiac assessment in 
patients with COVID-associated cardiomyopathy and heart 
failure. The American College of Cardiology recommends 
limiting ultrasound to those cases requiring medical 
decision-making and suggests the use of point-of-care 
ultrasound (POCUS) as an initial evaluation with focused 
echocardiography reserved for patients with more severe 
disease (28).
Modality-based challenges with COVID
Infection control and staff safety
The COVID-19 pandemic has strained the resources and 
capacity of many HIC. Details concerning the best practices 
for infection control have previously been published in this 
journal and are available online (29). In addition, there are a 
few considerations, specific to radiology including: 
  Clustering of all COVID patients requiring imaging into 
a single block of time to streamline efficiency and avoid 
the need for equipment decontamination after each 
patient, allowing staff to use a single set of personal 
protective equipment (PPE) for multiple patients.
  In rooms with adequate ventilation (6 air exchanges 
per hour) after a patient with COVID is imaged, it is 
recommended to wait one hour, including cleaning 
time, before imaging a non-COVID patient.
  Some sites in HIC are using a “double wipe-down” 
procedure—cleaning the ultrasound units first in the 
patient space and repeating, after a 2-minute drying 
time, outside of the isolation area.
Chest radiography
In LMIC, radiography and ultrasound are much more 
available than CT (30). In many sites in LMIC, portable 
radiography is not available and transportation of critically ill 
patients or even patients requiring oxygen, can be extremely 
challenging, restricting access to radiography.
Challenges with CXR include the requirement for 
technologists to don PPE and decontamination of the 
portable radiography unit after being used in the COVID 
isolation area. Novel approaches have been recommended 
to minimize both the risks of staff exposure as well as the 
need to decontamination including obtaining exposures 
through the glass doors or windows in isolation rooms and/
or using a greater than routine FFD (film-focus distance) of 
up to 3-4.5 meters to allow the mobile radiography unit to 
stay outside of the room antechamber (31). The University 
of Utah, Department of Radiology has online instructions 
[https://medicine.utah.edu/radiology/news/images/through-
glass-cxr-instructions.pdf] detailing the steps required to 
minimize staff exposure by safely performing through-glass 
chest X-ray. 
Computed tomography
CTs role in various diagnostic protocols varies widely. 
According to our Italian colleagues, initial imaging for 
COVID-19 suspected patients is a CXR. If the CXR is positive, 
the diagnosis is made. If the CXR is negative, ultrasound is 
performed and if more than 3 B-lines are noted, CT is then 
performed. On the other hand, French, Russian, and Kenyan 
radiologists report using CT preferentially both for diagnosis 
and to monitor clinical improvement. In the United States, 
the American College of Radiology does not recommend 
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Figure	3:		
An	axial	CT	image	obtained	without	intravenous	contrast	in	a	42‐year‐old	male	in	the	“late”	
time	group	(10	days	from	symptom	onset	to	this	CT)	shows	bilateral	consolidative	
opacities,	with	a	striking	peripheral	distribution	in	the	right	lower	lobe	(solid	arrows),	and	
with	a	rounded	morphology	in	the	left	lower	lobe	(dashed	arrow).		
	
	
	
	
	
Figure	4:	
Frequency	of	selected	chest	CT	findings	as	a	function	of	time	course	from	symptom	onset.	Figure 3. Frequency of selected che t CT fi dings as a finding of time course 
from symptom onset. (Bernheim et al., used with permission)
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Figure 4. Peripheral lobe ground glass opacities with 
new areas of consolidation on CT (arrows), observed 
five days following initial presentation with fever, 
cough, and productive sputum. Additional CT images 
demonstrated bilateral disease involvement. (Kong et 
al., used with permission)
Figure 5. Consolidation in bilateral lower lobes on CT, 
observed on day 13 of illness. (Wang et al., used with 
permission)
Figure 7. CT demonstrating crazy-paving in the 
periphery bilaterally, consisting of thickened 
interlobular and intralobular septa atop a background 
of ground glass opacity. Observed on day 10 after 
symptom onset. (Shi et al., used with permission)
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Figure 6. CT chest showing enlarged mediastinal and 
right hilar lymph nodes. In this patient, timing related 
to disease onset or disease severity is unclear. (Li et al., 
used with permission)
either chest X-ray or CT for diagnosis (32). Their guidelines 
express concern about the use of CT given that findings 
overlap with those of influenza and other viral pneumonias. 
As mentioned above, in locations with a high prevalence 
of COVID-19, this issue has less significance and with the 
continued uncertainty concerning RT-PCR testing in both 
timeliness and accuracy, CT is being selectively used in the 
U.S. to aid in patient care decisions. 
What emerges from all sides in this debate is that the ability 
to minimize contamination of staff and equipment, as 
well as the availability or scarcity of PPE, have overarching 
effects on selecting an imaging modality. We find that 
disparate decisions are being made on the ground by similar 
institutions in the same country.
Ultrasound
The potential of pulmonary ultrasound in suspected or 
confirmed COVID-19 patients has been reported but no 
blinded studies exist concerning its utility. In our informal 
survey of clinicians and radiologists from multiple countries, 
divergent views of ultrasound emerged. Proponents cite the 
lack of radiation, wide availability, often inexpensive devices, 
relative ease of machine cleaning, and the ability to perform 
serial examinations at the bedside. Detractors note that the 
risk of radiation, even from serial chest X-rays, is minimal in 
this setting, and that ultrasound risks prolonged proximity 
to the patient, is subject to operator dependency, and 
many sites lack experience with acquiring and interpreting 
pulmonary ultrasound images. 
Even within Europe, while we see many reports from Italy 
suggesting that ultrasound has much promise, at the same 
time, radiologists and several French radiologic societies 
have cautioned for sparing use of ultrasound due to the 
required close proximity to patients. Sites in Iran and 
Pakistan report that pulmonary ultrasound is not being 
used. We have anecdotal reports, from Russia, of handheld 
ultrasound being used for quick home assessment.
The Fleischner Society recently released their COVID 
guidelines. While their fundamental recommendations 
are important, ultrasound is explicitly not considered 
in these guidelines because of a paucity of experience 
and “infection control issues” (33). In the coorresponding 
author’s experience, tablet-based POCUS, with its paucity of 
knobs and keys, is easier to disinfect in most environments 
than either portable radiography equipment or standard 
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Figure 9. Left upper lobe peripheral opacities with 
reversed halo pattern (arrow). Timeframe from 
symptom onset unclear; however this was noted to 
progress to organizing changes on follow-up CT two 
days later, as observed in Figure 10. (Kong et al., used 
with permission)
Figure 10. Subpleural curvilinear opacities observed 
on CT, two days following initial presentation with fever 
and chills (arrows). (Kong et al., used with permission)
Figure 11. Follow-up CT with organizing changes. 
Timing from symptom onset unclear. (Kong et al., used 
with permission)
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Figure 8 (A-D). On presentation or day 3 of illness, 
CT demonstrated ground glass opacity (A) with 
progression to crazy paving pattern and partial 
consolidation (B) by day 7. Follow-up CT on days 11 (C) 
and 20 (D) showed continued resolution of initial GGO. 
(Pan et al., used with permission)
ultrasound units. 
Decision making
What lessons can we garner from the divergent use of 
imaging when attempting to offer guidance on imaging 
COVID-19 patients in LMIC? Obviously, local conditions, 
including the availability of PPE, CT, and skill at performing 
pulmonary ultrasound are major drivers. 
In choosing between chest X-ray and ultrasound in both 
sporadic and serial patient evaluation, local capabilities, 
availability of PPE and cleaning equipment, and the need 
to assess the entire chest (e.g. endotracheal tubes) will be 
the prominent drivers. In terms of decision-making, we 
have divided decision-making in imaging into three arenas: 
screening, triage, and management (Figures 13, 14).
Screening 
Despite early, optimistic reports concerning CT, imaging 
currently plays no primary role in screening patients for 
COVID-19. Selective use of imaging can be considered in 
patients with typical COVID-19 symptoms and a negative 
or pending RT-PCR test. Since patients with mild symptoms 
are typically sent home to self-isolate and not hospitalized, 
imaging should only rarely be performed in this population. 
Patients with mild symptoms but with an atypical clinical 
presentation may benefit from chest X-ray as a method 
for ruling out alternative cardiopulmonary diagnoses as 
well as documenting findings suggestive of COVID-19. No 
definitive data exists about the clinical utility of ultrasound 
for screening. 
Triage 
Decisions about disposition in patients with at least 
moderate disease are primarily driven by the clinical 
assessment including symptom severity, vital signs, 
pulse oximetry, etc. Imaging assessment of pulmonary 
involvement can offer clinicians an additional data point, 
especially in the situations in which hospital capacity is 
strained and the baseline extent of disease, particularly 
on CT, has been reported to predict both ICU admission 
and mortality (34). Ultrasound, chest X-rays, and CT can 
all be used in triage. Chest X-ray offers the advantage of 
familiarity, reproducibility, complete coverage of the thorax, 
and does not require the clinician time typically required 
to perform lung ultrasound. However, chest X-rays have 
been reported to be normal in ~30% of COVID-19 positive 
patients requiring hospitalization (3). In experienced hands 
and with appropriate PPE, ultrasound can be performed 
and offers portability. Although ultrasound is reported to be 
positive prior to chest X-ray abnormalities, the false negative 
rate of ultrasound for significant pulmonary pathology 
is currently unknown (35). In many LMIC settings there is 
limited availability of CT scanners, trained technologists, 
and radiologists capable of interpreting chest CT. CT should 
therefore be reserved for patients in whom other imaging is 
incongruent with the clinical assessment, or in whom occult 
cardiopulmonary disease, such as pulmonary emboli, is 
suspected.
Management 
In hospitalized patients, imaging can assist in evaluation 
of disease severity, progression, and the detection of 
acute respiratory distress syndrome (ARDS), bacterial co-
Score 0 Score 1 Score 2 Score 3
Pleural line (red arrow) is 
continuous, with “A-line” 
horizontal artifacts (blue 
arrow) visible
Indented pleural line (red 
arrows), with vertical areas 
of white (blue arrows) 
representing “B lines”
Broken pleural line (orange 
arrows) with small darker 
consolidated areas (red arrows) 
and areas of white lung (blue 
arrows)
Large, dense consolidations 
(darker areas, red arrows) 
with generalized white lung 
(orange arrow)
Figure 12. Lung ultrasound Score 0 through 3, as observed with linear transducer. (Adapted from Soldati et al., used with 
permission)
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Figure 13. Decision-making in screening and triage.
Figure 14. Decision-making in management.
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infection, pleural effusion, and pneumothorax. Although 
serial ultrasound by experienced practitioners is showing 
promise as a low-cost method to assess disease progression, 
chest X-ray is preferred for severely ill patients who require 
assessment of support tubes, such as endotracheal tubes. 
While the pulmonary physiology of ARDS in COVID-19 may 
have unique characteristics, the radiological appearance is 
similar to ARDS from other causes, including SARS (SARS-
CoV), with imaging playing a similar role in management.
Limitations
The greatest limitations in writing this article are the novel 
nature of this virus, the rapid evolution of the pandemic, 
and the absence of empirical data comparing the effect 
of different imaging modalities on patient outcome. In 
determining which modalities might be most effective, we 
are limited by the absence of recent data in LMIC on access 
to ultrasound and the relative availability of ultrasound 
(commonly POCUS) versus CXR, in small and medium-sized 
healthcare facilities. Also unknown is the capability of 
local clinicians to perform and interpret chest ultrasound. 
A survey, published in 2015, identifies lack of training as a 
primary barrier to regular use of ultrasound in LMICs (36). 
Despite the availability of online educational materials, this 
barrier will continue to be formidable for this novel use of 
ultrasound.
‘Resource constrained’ is often used in published articles, 
specifically with reference to LMIC. As we witness Italy, Spain, 
and New York City suddenly become resource constrained, 
COVID has taught us that resource constraints are not 
defined solely by a nation’s economics. Most LMIC have 
pockets of advanced radiology resources which coexist with 
large segments of the population lacking basic imaging 
(30). Although data only gradually became public, rates of 
illness and death are higher in communities of color than in 
the white population of the United States (37), highlighting 
that local economic and medical conditions constrain 
efforts to prevent and mitigate the spread of COVID by 
social distancing and self-quarantine. In this dystopic, 
pandemic-enveloped world, segmenting global radiology 
and constrained resources by country may be arcane. The 
environmental and medical resource limitations in LMIC 
clearly have homologues in areas of HIC. Perhaps the focus 
should be low-income areas (LIA) regardless of the country in 
which they exist?
Conclusion
In summary, we are living though a pandemic over a century 
beyond the devastation wrought by The Spanish Flu. We 
have a great amount of information about how imaging 
can potentially help diagnose and manage patients with 
COVID-19 but there is an absence of empirical data about 
which imaging modalities would be most appropriate in 
specific clinical situations. Radiologists and clinicians will 
need to continue making these decisions based on the 
evolving knowledge of COVID and the published anecdotal 
data. Those working in LMIC can be reassured that even 
in the absence of high-tech imaging, such as CT, the two 
basic imaging modalities of radiography and ultrasound 
can answer the vast majority of questions raised in the 
management of COVID-19 patients.
Addendum 1: Terminology
Chest X-ray: (As defined by Fleischner Society; Hansell et al.) 
(38)
  Ground glass opacities: Hazy increase in lung opacity 
without obscuration of pulmonary vessels.
  Consolidation: Homogenous increase in pulmonary 
parenchymal attenuation with obscuration of 
underlying vessels and airways. 
Chest CT: (As defined by Fleischner Society; Hansell et al.) 
(38)
  Ground-glass opacity: Hazy increased opacity of lung 
and preservation of bronchial, vascular margins. Refers 
to partial filling of airspaces, partial collapse of alveoli, 
and interstitial thickening.
  Consolidation: Homogenous increase in 
pulmonary parenchymal attenuation that obscures 
bronchovascular margins. Refers to exudate or other 
product of disease that replaces alveolar air.
  Crazy-paving pattern: Thickened interlobular septa and 
intralobular lines superimposed on a background of 
ground-glass opacity.
  Reverse halo (Atoll sign): Focal rounded area of ground-
glass surrounded by a ring of consolidation. 
Pulmonary Ultrasound: (Adapted from Lee) (35)
  A lines: Short, repetitive equidistant horizontal lines 
that fade with increasing depth; an artifact of the 
pleural line.
  B lines: Strong, narrow vertical artifact comprising of 
short horizontal lines that do not fade with depth; 
indicative of thickened pleura and or lung interstitium.
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